hemophilia

Deal terminate tear up end deal scrap
Biotech

Pfizer crashes Sangamo's stock by ending hem A gene therapy pact

Pfizer terminated a hemophilia A gene therapy pact to deprive the cash-strapped biotech of up to $220 million in milestones.
Nick Paul Taylor Jan 2, 2025 6:08am
Helophilia

Roche culls ph. 3 Spark gene therapy in hemophilia

Dec 16, 2024 12:24pm
Helophilia

Centessa drops hemophilia B drug following Pfizer’s Hympavzi win

Nov 12, 2024 9:45am
Graphic of a drop of blood made up of small data points and nodes

Pfizer gene therapy reduces bleeds in ph. 3 hemophilia A trial

Jul 24, 2024 8:44am
Helophilia

Novo unwraps phase 3 data on rival to Roche in hemophilia A

Jun 24, 2024 5:26am
showdown clash versus vs crash lightning fight dispute

Novo Nordisk's Hemlibra rival hits goals in phase 3

May 14, 2024 9:16am